Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

Autor: Arends, S., Van Nimwegen, J. F., Mossel, E., Van Zuiden, G. S., Delli, K., Stel, A. J., Van der Vegt, B., Haacke, E. A., Olie, L., Los, L., Verstappen, G. M., Pringle, S. A., Spijkervet, F. K. L., Kroese, F. G. M., Vissink, A., Bootsma, H.
Přispěvatelé: Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Translational Immunology Groningen (TRIGR), Personalized Healthcare Technology (PHT), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
Jazyk: angličtina
Zdroj: Annals of the Rheumatic Diseases, 79, 102-102. BMJ PUBLISHING GROUP
ISSN: 0003-4967
Databáze: OpenAIRE